Suchergebnis | Hamburg Open Science

Facetten

22 Einträge gefunden

Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
2009 - Forschungsinformationssystem des UKE
Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
2008 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
2008 - Forschungsinformationssystem des UKE
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
2007 - Forschungsinformationssystem des UKE
Prostate volume and adverse prostate cancer features: fact not artifact.
2007 - Forschungsinformationssystem des UKE
Management of erectile dysfunction after radical prostatectomy in 2007.
2007 - Forschungsinformationssystem des UKE
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
2007 - Forschungsinformationssystem des UKE
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.
2007 - Forschungsinformationssystem des UKE
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
2007 - Forschungsinformationssystem des UKE
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
2007 - Forschungsinformationssystem des UKE
Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.
2007 - Forschungsinformationssystem des UKE
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.

Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.

Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.

Prostate volume and adverse prostate cancer features: fact not artifact.

Management of erectile dysfunction after radical prostatectomy in 2007.

Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.

Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.

Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin.

Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.

Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

Development and external validation of an extended 10-core biopsy nomogram.